Skip to main content
Frontiers in Neurology logoLink to Frontiers in Neurology
. 2021 Nov 3;12:793620. doi: 10.3389/fneur.2021.793620

Erratum: Assessment of the Effect of Erenumab on Efficacy and Quality-of-Life Parameters in a Cohort of Migraine Patients With Treatment Failure in Cyprus

Frontiers Production Office 1,*
PMCID: PMC8596649  PMID: 34803901

Due to a production error, there was an error in affiliation 1 for author Andria Tziakouri. Instead of “Department of Neurology, Medical School, University of Nicosia, Nicosia, Cyprus,” it should be “Department of Neurology, American Medical Center, Nicosia, Cyprus.”

The publisher apologizes for this mistake. The original version of this article has been updated.


Articles from Frontiers in Neurology are provided here courtesy of Frontiers Media SA

RESOURCES